Drug intelligence / Profile preview

salbutamol + bromhexine + menthol

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Salbutamol + bromhexine + menthol is a fixed-dose combination (FDC) medication primarily used to treat respiratory conditions characterized by bronchospasm and excessive, viscous mucus. Salbutamol is a short-acting beta-2 adrenergic receptor agonist that promotes bronchodilation by increasing intracellular cAMP levels, which leads to the relaxation of bronchial smooth muscle. Bromhexine acts as a mucolytic and secretolytic agent; it increases the production of serous mucus in the respiratory tract and facilitates the breakdown of acid mucopolysaccharide fibers in thick phlegm, making it less viscous and easier to expectorate. Menthol is included for its cooling and soothing properties, which are mediated through the activation of TRPM8 receptors in the upper respiratory tract, providing relief from throat irritation and a mild antitussive effect. This combination is commonly prescribed as an oral syrup for patients suffering from productive cough associated with asthma, bronchitis, or chronic obstructive pulmonary disease (COPD).

Brand names
Asal-BMSalmaplon-BMMucocureS-BromSaliac-BM
Other names
salbutamol, bromhexine, and menthol combinationsalbutamol/bromhexine/menthol
02

Targets

ACE2 (Angiotensin-converting enzyme 2)ADRB1 (β1)ADRB2 (β2)TMPRSS2 (Transmembrane protease serine 2)

Beyond the preview

Go deeper on salbutamol + bromhexine + menthol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salbutamol + bromhexine + menthol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call